CERS Q3 2020 Earnings — Cerus Corporation Revenue & Financial Results | Market Cap Arena

CERSCerus Corporation

$335M

Q3 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$24M+31.0% YoY

Gross Profit

$13M53.6% margin

Operating Income

-$14M-59.2% margin

Net Income

-$14M-59.9% margin

EPS (Diluted)

$-0.08

QoQ Revenue Growth

+9.8%

Cash Flow

Operating Cash Flow

-$5M

Free Cash Flow

-$5M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$213M

Total Liabilities

$104M

Stockholders' Equity

$109M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$24M	$18M	+31.0%
Gross Profit	$13M	$10M	+21.3%
Operating Income	-$14M	-$17M	+17.5%
Net Income	-$14M	-$18M	+21.3%

Revenue Segments

Government Contract

$6M100%

Geographic Segments

Europe Middle East And Africa

$15M62%

North America

$8M36%

Other

$615,0003%